Blog

On March 17, CBA hosted the first workshop of the 2019 CBA Workshop Series at Stanford University, Graduate Community Center, Havana Room 750 Escondido Road, Palo Alto. About 60 people attended the event. This workshop featured four distinguished speakers – two from academia and two from industry – who shared with attendees the history of CNS drugs, CNS drug discovery models, and several novel applications for CNS drugs. Dr. Yadong Huang, Director and Senior Investigator at the Gladstone Center for Translational Advancement and Professor of Neurology and Pathology at UCSF, shared his research on ApoE4 as a drug target for Alzheimer’s Disease. Dr. David Yeomans, Director of Pain Research and Professor of Anethesiology, Perioperative, and Pain Medicine at Stanford School of Medicine, presented his work on the craniofacial analgesic effect of nasal application of a novel formulation of oxytocin. Dr. Tao Huang, co-founder and president of NeuCyte, shared with attendees an iPSC-derived neural cell model to help with CNS drug discovery. Dr. Jie Jack Li, a medicinal chemist at Revolution Medicines, gave attendees a history of CNS drugs.